Key features

• •Clearly summarizes the basic principles and research supporting cancer immunotherapy clinical translation
• •Contains expert guidance and treatment strategies for all immunotherapy classes and agents, including cell-based therapies, monoclonal antibodies, cytokine therapies, checkpoint inhibitors, oncolytic viruses, adjuvant approaches, and treatment combinations
• •Includes expert perspectives from leading authorities in the field
• •Provides information on all FDA-approved immunotherapies, including clinical management and outcome data
• •Discusses clinical aspects of immunotherapy for individual cancer types, including melanoma and other skin cancers, lung cancers, gynecologic cancers, gastrointestinal cancers, hematologic cancers, genitourinary cancers, head and neck cancers, sarcomas, brain and other CNS cancers, breast cancer, and pediatric malignancies.
• •Explains regulatory aspects behind the development and approval of immunotherapy drugs
• •Includes Online Access to the Digital Book